Quick Answer
ABEONA THERAPEUTICS INC. reported Stockholders Equity of $159.22 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed an increase of +261.6% in Stockholders Equity from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: -$17.08 million | Q1 2013: -$13.61 million | Q2 2013: -$12.35 million | Q3 2013: -$13.16 million | Q1 2014: -$15.49 million | Q2 2014: -$28.40 million | Q3 2014: -$30.36 million | Q1 2015: $3.16 million | Q2 2015: $59.95 million | Q3 2015: $73.07 million | Q1 2016: $65.66 million | Q2 2016: $61.48 million | Q3 2016: $63.49 million | Q1 2017: $95.71 million | Q2 2017: $89.08 million | Q3 2017: $89.88 million | Q1 2018: $169.74 million | Q2 2018: $160.92 million | Q3 2018: $150.25 million | Q1 2019: $117.79 million | Q2 2019: $107.16 million | Q3 2019: $96.05 million | Q1 2020: $132.38 million | Q2 2020: $121.05 million | Q3 2020: $115.11 million | Q1 2021: $94.39 million | Q2 2021: $84.09 million | Q3 2021: $79.74 million | Q1 2022: $21.18 million | Q2 2022: $14.02 million | Q3 2022: $12.40 million | Q1 2023: $18.74 million | Q2 2023: $9.35 million | Q3 2023: $22.04 million | Q1 2024: -$8.88 million | Q2 2024: $73.24 million | Q3 2024: $45.77 million | Q1 2025: $41.40 million | Q2 2025: $163.58 million | Q3 2025: $171.23 million.
- Over the full 16 years of available data (2010 to 2025), ABEONA THERAPEUTICS INC.'s Stockholders Equity has grown by 865.6%.
- Historical annual values: Fiscal year 2025: $159.22 million | Fiscal year 2024: $44.03 million | Fiscal year 2023: $14.83 million | Fiscal year 2022: $26.76 million | Fiscal year 2021: $42.37 million | Fiscal year 2020: $102.55 million | Fiscal year 2019: $178.43 million | Fiscal year 2018: $134.05 million | Fiscal year 2017: $170.10 million | Fiscal year 2016: $99.10 million | Fiscal year 2015: $67.72 million | Fiscal year 2014: $4.82 million | Fiscal year 2013: -$14.78 million | Fiscal year 2012: -$17.08 million | Fiscal year 2011: -$17.61 million | Fiscal year 2010: -$20.80 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: